Indian pharma firm Dr Reddy's Laboratories has made its first foray into the nutritional space in the country with a diabetic drink, Celevida.
The drink is said to help manage blood glucose levels among Indian patients.
Diabetes is a growing challenge in India with 73 million people suffering from diabetes, and 80 million people with pre-diabetes, and the country is expected to have the world’s largest diabetes population by 2035. Changing habits of diet and a sedentary lifestyle have contributed to the rise of diabetes in the growing population.
The company’s chief executive officer of branded markets (India and emerging markets), M V Ramana told NutraIngredients-Asia the move into nutrition drinks was “part of our overall strategy to strengthen our business portfolio for high-growth therapy areas. Nutrition is shown in various studies to improve clinical outcomes as well as quality-of-life in several disease conditions.”